Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleThe Illustrated Post

[68Ga]Ga-FAPI-46 False-Positive Uptake After Chemotherapy in Nonseminomatous Germ Cell Tumor Metastatic Lesions

Vinicius Ludwig, Peter George Maliha, John Shen, David Tonnelet, Steve Raman, Mark S. Litwin and Jeremie Calais
Journal of Nuclear Medicine August 2024, 65 (8) 1328-1329; DOI: https://doi.org/10.2967/jnumed.124.267609
Vinicius Ludwig
1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter George Maliha
1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California;
2Nuclear Medicine, Centre Hospitalier de l’Université de Montréal Centre de Recherche, Université de Montréal, Montréal, Québec, Canada;
3Nuclear Medicine Department, Centre Hospitalier de l’Université de Montréal, Montréal, Québec, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Shen
4Department of Hematology/Oncology, UCLA, Los Angeles, California;
5Department of Urology, David Geffen School of Medicine, UCLA, Los Angeles, California;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Tonnelet
6Department of Nuclear Medicine, Henri Becquerel Cancer Center, and QuantIF–LITIS, University of Rouen, Rouen, France; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steve Raman
7Department of Radiology, UCLA, Los Angeles, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark S. Litwin
5Department of Urology, David Geffen School of Medicine, UCLA, Los Angeles, California;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremie Calais
1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 65 no. 8 1328-1329
DOI 
https://doi.org/10.2967/jnumed.124.267609
PubMed 
38664018

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication February 14, 2024
  • Accepted for publication March 25, 2024
  • Published online August 1, 2024.

Article Versions

  • previous version (April 25, 2024 - 09:17).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: April 2024 to April 2025

AbstractFullPdf
Apr 20240246105
May 202408722
Jun 2024063
Jul 2024078
Aug 2024064788
Sep 2024020035
Oct 2024015436
Nov 2024016419
Dec 2024011223
Jan 202506032
Feb 202507823
Mar 202505245
Apr 202505740
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 65 (8)
Journal of Nuclear Medicine
Vol. 65, Issue 8
August 1, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
[68Ga]Ga-FAPI-46 False-Positive Uptake After Chemotherapy in Nonseminomatous Germ Cell Tumor Metastatic Lesions
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
[68Ga]Ga-FAPI-46 False-Positive Uptake After Chemotherapy in Nonseminomatous Germ Cell Tumor Metastatic Lesions
Vinicius Ludwig, Peter George Maliha, John Shen, David Tonnelet, Steve Raman, Mark S. Litwin, Jeremie Calais
Journal of Nuclear Medicine Aug 2024, 65 (8) 1328-1329; DOI: 10.2967/jnumed.124.267609

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
[68Ga]Ga-FAPI-46 False-Positive Uptake After Chemotherapy in Nonseminomatous Germ Cell Tumor Metastatic Lesions
Vinicius Ludwig, Peter George Maliha, John Shen, David Tonnelet, Steve Raman, Mark S. Litwin, Jeremie Calais
Journal of Nuclear Medicine Aug 2024, 65 (8) 1328-1329; DOI: 10.2967/jnumed.124.267609
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Uncommon Anomalous Biodistribution of 18F-DCFPyL Prostate-Specific Membrane Antigen: A Case Series
  • [68Ga]Ga-FAPI PET/CT Monitors Response to Receptor Activator of Nuclear Factor-κB Ligand Inhibitor in a Giant Cell Tumor of Bone: Correlation with Histopathology
  • Evaluating Bone Healing with [18F]NaF PET/CT During Bone Segment Transport in Femoral Fracture Treatment
Show more The Illustrated Post

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire